1. Our vision
  2. Media

Media

Displaying 1 - 5 of 5
Santen confirmed as Marketing Authorisation Holder of Rhokiinsa® and Roclanda® in the EEA and UK after transfer from Aerie Pharmaceuticals
For healthcare business and investor press only
Read more
Santen establishes its first external research laboratory in Europe at the UCL Institute of Ophthalmology in London
For UK national/UK healthcare professional and pharmaceutical trade media/European healthcare professional and pharmaceutical trade media 
Read more
Santen announces global collaboration with Massachusetts Eye and Ear and Ulster University researchers to study and develop novel treatments for glaucoma
Santen, a global company specialising in ophthalmology, is delighted to announce a partnership with scientists from 
Read more
Survey suggests that people living with glaucoma are potentially at increased risk of sight loss and blindness due to COVID-19 pandemic
Results reinforce the importance of continuing eye care routines to maintain good eye health
Read more
Glaucoma UK and Santen UK partner to tackle one of the major challenges in glaucoma therapy, patient adherence to medication
14 December 2020 – St Albans, UK – Santen UK, the global specialist company in ophthalmology, announces the launch of the Glaucoma Adherence Toolkit, in collaboration with the charity
Read more
Next: Media enquiries
Back to top